Global Regenerative Medicine Market Growth (Status and Outlook) 2023-2029

Global Regenerative Medicine Market Growth (Status and Outlook) 2023-2029

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.

Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

LPI (LP Information)' newest research report, the “Regenerative Medicine Industry Forecast” looks at past sales and reviews total world Regenerative Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Regenerative Medicine sales for 2023 through 2029. With Regenerative Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Regenerative Medicine industry.

This Insight Report provides a comprehensive analysis of the global Regenerative Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Regenerative Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Regenerative Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Regenerative Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Regenerative Medicine.

The global Regenerative Medicine market size is projected to grow from US$ 32640 million in 2022 to US$ 116410 million in 2029; it is expected to grow at a CAGR of 19.9% from 2023 to 2029.

Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.

North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.

In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Regenerative Medicine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Cell Therapy

Tissue Engineering

Biomaterial

Other

Segmentation by application

Dermatology

Cardiovascular

CNS

Orthopedic

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

J & J (DePuy Synthes)

Medtronic

Zimmer Biomet

Stryker

Allergan(Acelity)

MiMedx Group

Organogenesis

Fujifilm Cellular Dynamics

Osiris Therapeutics

Vcanbio

CCBC

Cytori

Celgene

Vericel Corporation

Guanhao Biotech

Mesoblast

AMAG Pharmaceuticals (CBR)

ViaCord

CordLife

Integra LifeSciences

Nuvasive

Cook Biotech

Japan Tissue Engineering

Please note: The report will take approximately 2 business days to prepare and deliver.